FXYD6 and CASQ2, which are involved in ion channel activity, have only been mentioned in a small number of bioinformatics analyses of BLCA without the support of real-world data21,22, but have been revealed to promote tumor progression and regulate tumor-microenvironmental interactions in hepatocellular carcinoma and breast cancer23,24. Here, CASQ2 is linked to neoplasm.